Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
1.27
-
NAV
₹14.16
-
Fund Started
08 Apr 2024
-
Fund Size
₹163.78 Cr
-
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
-
1 Year
17.14%
-
3 Year
-
-
5 Year
-
-
Equity
100.08%
-
Cash
-0.08%
-
Top 10 Holdings
Lupin Ltd. | 9.88% |
Fortis Healthcare Ltd. | 8.50% |
Laurus Labs Ltd. | 7.57% |
Aurobindo Pharma Ltd. | 6.86% |
Glenmark Pharmaceuticals Ltd. | 6.40% |
Alkem Laboratories Ltd. | 5.58% |
Biocon Ltd. | 4.54% |
Mankind Pharma Ltd. | 4.49% |
Ipca Laboratories Ltd. | 3.76% |
Aster DM Healthcare Ltd. | 3.14% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
-
Launch Date
08 Apr 2024
-
